Cold Plasma as a Revolutionary Antimicrobial Modality: A Multifaceted Weapon Against Antibiotic Resistance
Antibiotics · 14.09.2025 · 14 (9) · 930
DOI: 10.3390/antibiotics14090930 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 14.09.2025. Verfasst von Yehia A-G Mahmoud und 6 weiteren Autor:innen. Beteiligte Einrichtung: Botany and Microbiology Department, Faculty of Science, Tanta University, Tanta 31527, Egypt. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The rise of antibiotic resistance has transformed once-curable infections into urgent global health threats, leaving hospitals with outbreaks, patients with prolonged illnesses, and doctors with limited therapeutic options. The era of antibiotic resistance is no longer a distant concern; it is a pressing reality demanding innovative solutions. Among emerging alternatives, cold plasma a partially ionized state of matter enriched with reactive species offers a multi-targeted antimicrobial strategy. Unlike conventional antibiotics, cold plasma disrupts bacterial survival through diverse mechanisms, including membrane rupture, protein and nucleic acid damage, and oxidative stress that overwhelms microbial defenses. This review synthesizes current evidence on the mechanisms of cold plasma, the factors influencing its antimicrobial efficacy, and its applications across healthcare, food safety, and environmental protection. In addition, it highlights the synergistic potential of cold plasma when combined with antibiotics, nanomaterials, or bacteriophages to enhance effectiveness against resistant pathogens. While challenges remain regarding safety validation, standardization, and large-scale application, cold plasma represents a promising non-traditional approach to complement existing therapies. This review not only summarizes recent progress but also outlines future directions, emphasizing its potential role in combating antibiotic resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Botany and Microbiology Department, Faculty of Science, Tanta University, Tanta 31527, Egypt.
- Applied and Analytical Microbiology Department, Faculty of Science, Ain Shams University, Ain Shams 11772, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
- Botany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
ORCID-Profile: Yehia A-G Mahmoud, Nehal E Elkaliny, Kamel Metwally, Galal Yahya, Sameha Sherif
Zitieren
APA
Mahmoud, Y. A., Elkaliny, N. E., Elshikh, F. M., Ashraf, Y., Metwally, K., Yahya, G., & Sherif, S. (2025). Cold Plasma as a Revolutionary Antimicrobial Modality: A Multifaceted Weapon Against Antibiotic Resistance. Antibiotics, 14(9), 930. https://doi.org/10.3390/antibiotics14090930
Vancouver
Mahmoud YA, Elkaliny NE, Elshikh FM, Ashraf Y, Metwally K, Yahya G, et al. Cold Plasma as a Revolutionary Antimicrobial Modality: A Multifaceted Weapon Against Antibiotic Resistance. Antibiotics. 2025;14(9):930. doi:10.3390/antibiotics14090930
BibTeX
@article{Mahmoud2025,
author = {Mahmoud, Yehia A-G and Elkaliny, Nehal E and Elshikh, Farah M and Ashraf, Yara and Metwally, Kamel and Yahya, Galal and Sherif, Sameha},
title = {Cold Plasma as a Revolutionary Antimicrobial Modality: A Multifaceted Weapon Against Antibiotic Resistance},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {9},
pages = {930},
doi = {10.3390/antibiotics14090930}
}
EUVIMED